CCT241161

News alerts, weekly reports and conference planners

Company:

Institute of Cancer Research, The University of Manchester

Drug class:

pan-RAF inhibitor, SRC-family kinase (SFK) inhibitor

Related drugs:

NRAS mutation	Melanoma	NRAS mutation	Melanoma	CCT241161 + CCT196969 Sensitive: D – Preclinical CCT241161 + CCT196969 Sensitive : D	CCT241161 + CCT196969 Sensitive: D – Preclinical CCT241161 + CCT196969 Sensitive : D
NRAS mutation	Melanoma	NRAS mutation	Melanoma	CCT241161 Sensitive: D – Preclinical CCT241161 Sensitive : D	CCT241161 Sensitive: D – Preclinical CCT241161 Sensitive : D

Associations
(2)